Stockscreener 앱 받기
3.61
7.44%
0.25
시간 외 거래:
3.61
전일 마감가:
$3.36
열려 있는:
$3.35
하루 거래량:
22,536
Relative Volume:
0.41
시가총액:
$6.41M
수익:
$770.00K
순이익/손실:
$-38.84M
주가수익비율:
-0.2541
EPS:
-14.2049
순현금흐름:
$-43.02M
1주 성능:
+17.21%
1개월 성능:
-15.46%
6개월 성능:
-60.02%
1년 성능:
-66.62%
1일 변동 폭
$3.34
$3.622
1주일 범위
$3.00
$3.622
52주 변동 폭
$2.84
$37.50
Lyra Therapeutics Inc Stock (LYRA) Company Profile
명칭
Lyra Therapeutics Inc
전화
617-373-4600
주소
480 ARSENAL WAY, WATERTOWN, MA
LYRA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LYRA
Lyra Therapeutics Inc
|
3.61 | 5.96M | 770.00K | -38.84M | -43.02M | -14.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Lyra Therapeutics Inc Stock (LYRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-05-07 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2024-05-07 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-05-07 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-05-06 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-10-06 | 재개 | BTIG Research | Buy |
| 2023-08-31 | 개시 | H.C. Wainwright | Buy |
| 2022-05-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-05-26 | 개시 | BTIG Research | Buy |
| 2020-05-26 | 개시 | BofA/Merrill | Buy |
| 2020-05-26 | 개시 | Jefferies | Buy |
| 2020-05-26 | 개시 | William Blair | Outperform |
모두보기
Lyra Therapeutics Inc 주식(LYRA)의 최신 뉴스
Will Lyra Therapeutics Inc. stock outperform value stocks2026 world cup usa national team round of 16 defensive leaders high defensive line match prediction expert opinion - ulpravda.ru
Can Lyra Therapeutics Inc. stock sustain revenue growth2026 world cup usa national team qualification playmakers pressing system winner prediction guide - ulpravda.ru
Lyra Therapeutics (NASDAQ:LYRA) Trading Up 0.3% – Time to Buy? - Defense World
LYRA (Lyra Therapeutics) EV-to-OCF : -0.46 (As of Dec. 22, 2025) - GuruFocus
Can Lyra Therapeutics Inc. stock surprise with earnings upside2025 Historical Comparison & Free AI Powered Buy and Sell Recommendations - Bölüm Sonu Canavarı
Is Lyra Therapeutics Inc. stock a buy for dividend growthJuly 2025 Movers & Low Risk High Win Rate Stock Picks - Улправда
Lyra Therapeutics Earnings Notes - Trefis
Take Profit: Will Lyra Therapeutics Inc. stock outperform value stocksPortfolio Performance Report & Expert Curated Trade Setup Alerts - Улправда
Why Lyra Therapeutics Inc. stock remains on buy listsJuly 2025 WrapUp & Weekly High Momentum Picks - Улправда
Insmed drops as it abandons brensocatib in rhinosinusitis - Seeking Alpha
Lyra Therapeutics Stock Rockets 56% With 6-Day Winning Streak - Trefis
Will Lyra Therapeutics Inc. stock pay special dividends2025 Trade Ideas & High Conviction Investment Ideas - Newser
Lyra Therapeutics (LYRA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Why Lyra Therapeutics Inc. stock is popular among millennials2025 Investor Takeaways & Expert Approved Momentum Ideas - Newser
Will Lyra Therapeutics Inc. stock benefit from infrastructure spendingQuarterly Earnings Summary & Stepwise Entry/Exit Trade Alerts - Newser
Published on: 2025-11-27 15:46:05 - moha.gov.vn
PERCEPTIVE ADVISORS LLC Reduces Stake in Lyra Therapeutics Inc - GuruFocus
Will Product Innovation Drive Hisar Spinning Mills Limited Stock in YEARRisk Management Strategies & Free Extraordinary Earning Power - earlytimes.in
Will Lyra Therapeutics Inc. stock deliver shareholder valueMarket Growth Summary & High Accuracy Trade Signal Alerts - newser.com
Can Lyra Therapeutics Inc. stock deliver sustainable ROEBull Run & Consistent Return Strategy Ideas - newser.com
What technical charts say about Lyra Therapeutics Inc. stockVolume Spike & Weekly Watchlist for Hot Stocks - newser.com
How to interpret RSI for Lyra Therapeutics Inc. stock2025 Short Interest & Stepwise Trade Signal Guides - newser.com
Will Lyra Therapeutics Inc. outperform the marketEarnings Risk Report & Detailed Earnings Play Alerts - newser.com
How to escape a deep drawdown in Lyra Therapeutics Inc.July 2025 Recap & Weekly Market Pulse Alerts - newser.com
Is Lyra Therapeutics Inc. stock in correction or buying zoneJuly 2025 Summary & Scalable Portfolio Growth Methods - newser.com
Is Lyra Therapeutics Inc. stock overvalued by current metricsExit Point & Intraday High Probability Setup Alerts - newser.com
What machine learning models say about Lyra Therapeutics Inc.Trade Volume Report & AI Driven Stock Reports - newser.com
What valuation multiples suggest for Lyra Therapeutics Inc. stockJuly 2025 Levels & Weekly Return Optimization Alerts - newser.com
Risk adjusted return profile for Lyra Therapeutics Inc. analyzedMarket Weekly Review & Growth Focused Investment Plans - newser.com
Can a trend reversal in Lyra Therapeutics Inc. lead to recoveryWeekly Trade Report & Weekly Breakout Stock Alerts - newser.com
Lyra Therapeutics Faces Critical Juncture as Challenges Mount - Ad-hoc-news.de
Lyra Therapeutics Inc (LYRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Lyra Therapeutics Inc 주식 (LYRA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Nov 13 '25 |
Sale |
3.90 |
31,810 |
124,062 |
14,026 |
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Nov 12 '25 |
Sale |
4.06 |
8,745 |
35,499 |
17,239 |
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Nov 11 '25 |
Sale |
4.31 |
5,320 |
22,954 |
18,122 |
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Nov 06 '25 |
Sale |
5.18 |
32,149 |
166,529 |
22,521 |
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Nov 07 '25 |
Sale |
4.75 |
19,739 |
93,695 |
20,528 |
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Nov 10 '25 |
Sale |
4.54 |
18,502 |
83,995 |
18,659 |
28.63%
자본화:
|
볼륨(24시간):